Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 24, 2019

SELL
$12.3 - $35.76 $86,100 - $250,320
-7,000 Closed
0 $0
Q1 2019

May 01, 2019

SELL
$20.77 - $42.37 $62,310 - $127,109
-3,000 Reduced 30.0%
7,000 $271,000
Q1 2018

May 02, 2018

BUY
$59.7 - $99.25 $119,400 - $198,500
2,000 Added 25.0%
10,000 $680,000
Q4 2017

Feb 06, 2018

SELL
$93.85 - $132.45 $93,850 - $132,450
-1,000 Reduced 11.11%
8,000 $791,000
Q3 2017

Oct 30, 2017

BUY
$72.0 - $119.75 $648,000 - $1.08 Million
9,000
9,000 $1.08 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $141M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Nj State Employees Deferred Compensation Plan Portfolio

Follow Nj State Employees Deferred Compensation Plan and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.